AFP and hepatocellular carcinoma: In the present study, an UPLC-MS-based lipidomic expression signature successfully distinguished HBV-HCC cases from HBV-LC with 78.1 % sensitivity and 63.6 % specificity and provided a more precise diagnostic instrument for cirrhotic patients than conventional non-invasive biomarker detection (AFP).